Townsend Letter Shines a Light on GcMAF
- The Bioregulatory Medicine Institute
- Feb 7, 2020
- 1 min read
Updated: Mar 5, 2024
An article by BRMI Medical Director James Odell, ND, OMD, LAc, appears in this month's Townsend Letter - entitled "Globulin Component Macrophage Activating Factor (GcMAF) Immunotherapy". Click here to access the article - and learn how GcMAF activates tumoricidal macrophages, leading to tumor regression.
